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The authors evaluated the association of prenatal arsenic exposure with size at birth (birth weight, birth length,
head and chest circumferences). This prospective cohort study, based on 1,578 mother-infant pairs, was con-
ducted in Matlab, Bangladesh, in 2002–2003. Arsenic exposure was assessed by analysis of arsenic in urine
collected at around gestational weeks 8 and 30. The association of arsenic exposure with size at birth was
assessed by linear regression analyses. In analysis over the full range of exposure (6–978 lg/L), no dose-effect
association was found with birth size. However, signiﬁcant negative dose effects were found with birth weight and
head and chest circumferences at a low level of arsenic exposure (<100 lg/L in urine). In this range of exposure,
birth weight decreased by 1.68 (standard error (SE), 0.62) g for each 1-lg/L increase of arsenic in urine. For head
and chest circumferences, the corresponding reductions were 0.05 (SE, 0.03) mm and 0.14 (SE, 0.03) mm per
1 lg/L, respectively. No further negative effects were shown at higher levels of arsenic exposure. The indicated
negative effect on birth size at a low level of arsenic exposure warrants further investigation.
arsenic; Bangladesh; birth weight; cohort studies; maternal exposure; urine
Abbreviations: GW, gestational week; HDSS, health and demographic surveillance system; ICDDR,B, International Centre for
Diarrhoeal Disease Research, Bangladesh; MINIMat, Maternal and Infant Nutrition Interventions, Matlab; SD, standard deviation;
SE, standard error.
Size at birth is an important determinant of morbidity
and mortality in early childhood (1, 2), as well as of
chronic diseases in adulthood (3, 4). The intrauterine and
early childhood periods are the most biologically sensitive
windows for chemicals that may impair growth and organ
development. Even the common environmental concentra-
tions of pollutants that would otherwise be harmless might
be harmful during early child development (5). Millions of
people worldwide, particularly in Bangladesh and West
Bengal, India, are using tube-well water with elevated con-
centrations of arsenic, often due to dissolution of naturally
occurring arsenic in the bedrock or by anthropogenic emis-
sions (6–8). Arsenic is a potent and highly reactive toxi-
cant and carcinogen, and there is increasing concern that it
may adversely affect intrauterine and child development.
Arsenic easily crosses the placenta in both animals and
humans (9, 10), and thus fetuses may be exposed to arsenic.
Several studies suggest association between arsenic expo-
sure and adverse pregnancy outcomes, such as spontaneous
abortion and stillbirth, and infant death (11–15). A few
studies have suggested a negative association between arse-
nic exposure and birth weight. An overall 29-g reduction of
birth weight was observed in an arsenic-exposed area in
Taiwan, where the household members used well water with
arsenic concentrations varying between undetectable levels
and 3,590 lg/L (16). In Chile, a nonsignificant difference of
57 g of birth weight was detected between Antofagasta and
Valparaiso, with drinking water arsenic concentrations
around 40 lg/L and below 1 lg/L, respectively (17). These
studies were ecologic in design, and therefore the differ-
ences presented might be biased. They also lack information
on other measurements of birth anthropometry. Therefore,
the objective of our study was to evaluate the association
between individually assessed arsenic exposures in a cohort
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of pregnant women in Matlab, Bangladesh, and size at birth
(birth weight, birth length, head circumference, and chest
circumference).
MATERIALS AND METHODS
Study area
The study was conducted in the Matlab area located
53 km southeast of Dhaka, where the International Centre
for Diarrhoeal Disease Research, Bangladesh (ICDDR,B),
has a rural field research station and has been running
a health and demographic surveillance system (HDSS) since
1966. Community health research workers visit every
household monthly to update vital events in the families.
In the area, about 70% of tube wells had an arsenic concen-
tration exceeding the World Health Organization’s guideline
value of 10 lg/L (18). This study was conducted in the part
of the area (about 110,000 inhabitants) where ICDDR,B
provides health service to women of reproductive ages and
children under 5 years of age.
Study design and subjects
This prospective cohort study was nested into a supple-
mentation trial (Maternal and Infant Nutrition Interventions,
Matlab (MINIMat), Study) that enrolled pregnant women
from November 2001 to October 2003. Pregnancies were
identified at the monthly household visits of community
health research workers, who offered a urine pregnancy test
to women who had missed a menstrual period. All women
with a positive test were invited to visit their health center
for further assessment. Women were enrolled in the MINIMat
Study if the following eligibility criteria had been met:
viable fetus by ultrasound examination, gestational age of
less than 13 weeks, women had no severe illness, and
women had consented to participation.
Starting in January 2002, women with a pregnancy-
positive test were requested to donate a urine sample for
arsenic analysis. In addition to this urine sample, commonly
collected around gestational week (GW) 8, urine samples
were also obtained around GW30 during visits for an ante-
natal check-up at a health center. To cover a full year of
potential variations in arsenic exposure and size at birth,
our study included women identified as pregnant from
February 1, 2002, to January 31, 2003, and enrolled in the
MINIMat Study. Out of 1,697 women with singleton births
where sizes at birth were measured, 1,578 had urinary
arsenic concentration data at both GW8 and GW30 and,
therefore, were included in this analysis (Figure 1).
Ethical consideration
A concurrent study of arsenic and its health consequences
in Matlab (known as the AsMat Study) included interviews
of all inhabitants in the study area over 4 years of age about
their drinking water history and also assessed the arsenic
content in the tube-well water in the area by field kits (18).
Tube wells with arsenic levels of greater than 50 lg/L were
painted red, and those with arsenic levels of 50 lg/L or less
were painted green in accordance with the Bangladesh gov-
ernment program. Pregnant women were advised to drink
water from the green tube wells. We were not able to inform
individual mothers about their level of arsenic exposure
Figure 1. Study participation of the pregnancy cohort based on availability of urine arsenic concentrations at gestational weeks 8 and 30 and
measurement of size at birth in Matlab, Bangladesh, 2002–2003. GW, gestational week; MINIMat, Maternal and Infant Nutrition Interventions,
Matlab.
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measured in urine because of delayed analyses of those
samples abroad. The study was approved by the Ethical
Review Committee of ICDDR,B.
Exposure assessment
Arsenic exposure was assessed by the concentration of
inorganic arsenic and methylated metabolites in urine at
around week 8 and week 30 in pregnancy. Although the
half-time of arsenic in the body is in the order of a few days
only, it is likely that women had reached a steady-state level
of excretion of arsenic and its metabolites through urine due
to continuous exposure via drinking water. In early preg-
nancy, the urine samples were collected at the woman’s
home, and later on the samples were collected at the health
facility. When collected at home, the samples were chilled
with cooling blocks and transported to the Matlab laboratory
where they were stored frozen at 70C. The details of
urine sample collection and temperature maintenance dur-
ing transportation have been described elsewhere (19). The
sum of the inorganic arsenic and methylated metabolites in
urine was determined by using hydride generation-atomic
absorption spectrophotometry in Sweden (19, 20). The de-
tection limit of this spectrophotometric method was 1.3 6
0.27 lg/L. We also participated in interlaboratory compar-
isons of arsenic metabolites in urine to verify the analytical
accuracy (21). In order to compensate for variation in the
dilution of the urine, caused by variation in fluid intake, time
of sampling, temperature, and physical activity, we adjusted
the obtained concentrations by specific gravity (the average
being 1.012 g/mL). The specific gravity adjustment of urine
dilution is less influenced by muscle mass and nutritional
status than is the more commonly used creatinine adjustment
(22–24).
Outcome and covariate
Outcome information was collected prospectively by
a team of workers especially recruited and trained with
the data tools for the MINIMat Study. About 40% of birth
anthropometry was measured in the health facilities, where
delivery took place. For women who delivered at home,
a birth notification system was established, and birth sizes
were measured by paramedics mostly within 24 hours of
birth. Anthropometric data were collected following stan-
dard procedures (25). Birth weight was taken by electronic
scales (SECA, Hamburg, Germany) with a precision of 10 g.
Birth length was measured with a locally made wooden
scale with a precision of 1 mm. Circumferences (head and
chest) were measured by a tape with precision of 1 mm. We
included the adjusted birth anthropometry in the analysis for
the variation of measurement time after birth as described
elsewhere (26).
Covariate information was obtained from 2 databases
(i.e., MINIMat Study and HDSS). In the MINIMat Study,
information was collected prospectively during household
visits of health workers or during routine visits of women at
health facilities. Gestational age was calculated by subtract-
ing the last menstrual period date from the date of birth of
the infant. The last menstrual period was obtained by inter-
viewing the woman during the process of pregnancy iden-
tification. In the analyses, we included the last menstrual
period by ultrasound measurement for the women who
could not remember their last menstrual period (26 women).
Women’s height and weight were taken during the first visit
to the respective health center (mostly around GW8). Body
mass index was calculated as weight (kg)/height (m)2.
Educational status was expressed as the number of years
of formal schooling completed by the mother. A wealth
score, derived largely from household assets, was created
by using principal components analysis and categorized into
quintiles (27). The history of betel-nut chewing and/or to-
bacco smoking was obtained. We obtained information on
age and parity from the HDSS databases. Season of birth
was categorized as premonsoon (January–May), monsoon
(June–September), and postmonsoon (October–December).
Statistical analysis
Arsenic exposure was expressed as the average arsenic
concentrations in urine (mean concentration of GW8 and
GW30) to obtain an exposure measure representing a large
part of the pregnancy. The advantage of having arsenic ex-
posure at 2 measurement points was also taken and used to
evaluate the outcome by early and late exposures separately.
Associations between covariates and exposure and out-
come were evaluated to identify potential confounders. The
level of significance was determined by analysis of variance
or by Spearman’s correlation coefficient as appropriate for
the data being analyzed. A covariate was defined as a poten-
tial confounder if it was found to be associated with both
exposure and outcome at a significance level of P  0.20.
Any covariate found to change the effect estimate by 5% or
more was included in the multivariate model to adjust for
potential confounding. Categorical variables were entered in
the model by producing dummy variables.
The association between average arsenic exposure and
size at birth was assessed with a least-squared linear regres-
sion model analysis evaluating any linear association over
the full range of exposure. In addition, exposure and out-
come data were examined by plotting scattergraphs that in-
cluded locally weighted regression scatterplot smoothing
for a moving fitted-average line (referred to henceforth as
the ‘‘loess line’’). The loess line indicated a negative dose
effect of arsenic exposure on size at birth in the lower range
of exposure (<100 lg/L), after which the line leveled out
and no further negative dose effect was observed (Figure 2).
The suggested pattern of dose effect in the graphs was
statistically tested by modeling size at birth as a function
of arsenic concentration (continuous variable), level of
exposure (categorical variable with exposure of arsenic at
<100 lg/L coded ¼ 0 and at 100 lg/L coded ¼ 1), and
a variable capturing the interaction between these two var-
iables. Coding the variable ‘‘level of exposure’’ to 0 provided
an estimation of the dose effect of arsenic in the lower range
of exposure. We also evaluated the dose effect of arsenic at
the higher level of exposure by reversing the codes of the
‘‘level of exposure’’ variable and constructing a new inter-
action variable. The analytical strategy used in this study has
been used elsewhere (28, 29).
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To assess the robustness of the dose-effect association
between arsenic exposure and size at birth, we also evalu-
ated the multivariate model entering all covariates (asset
score, body mass index, height, age, education, season, ges-
tational age at birth, and sex of infant) that were found to be
significantly associated with outcome variables in the un-
adjusted analyses.
The above outlined steps in statistical analyses were also
applied when evaluating the effect of low-level arsenic ex-
posure at early (GW8) and late (GW30) gestational periods
on size at birth. All the analyses were performed in SPSS,
version 14, software (SPSS, Inc., Chicago, Illinois).
RESULTS
In total, 1,578 (93%) mother-infant pairs had data on uri-
nary arsenic concentrations in both early (GW8) and late
(GW30) pregnancy. Table 1 presents background character-
istics and arsenic concentrations in the urine of study women.
Mothers’ age ranged from 15 to 44 years with a mean age of
27 years. The mean height and weight of the women at GW8
were 149.6 (standard deviation (SD), 5.2) cm and 45.0 (SD,
6.6) kg, respectively; about one-third of women were mal-
nourished (body mass index < 18.5 kg/m2). The mean ges-
tational age at birth was 39.3 (SD, 1.7) weeks. Eleven percent
of infants were born preterm (<37 weeks). In this cohort,
women did not smoke cigarettes; however, about 62% re-
ported betel-nut chewing during pregnancy.
The mean gestational age at the time of urine sample
collection in early (GW8) and late (GW30) gestational pe-
riods, as determined by last menstrual period, was 8 (SD, 2)
weeks and 30 (SD, 6) weeks, respectively. The median ar-
senic concentration in GW8 was 79 lg/L with a mean of
152 lg/L. In GW30, the median and mean arsenic concen-
trations were 80 lg/L and 167 lg/L, respectively. Further
details about the exposure are published elsewhere (19).
Arsenic exposure was not associated with allocation to food
and micronutrient randomization groups in the MINIMat
Study.
Descriptive data on the outcomes and newborns are given
in Table 2. Forty-eight percent of the infants were females.
The mean birth weight was 2,681 (SD, 401) g, and 32% had
low birth weight (<2,500 g).
The mother’s body mass index, education, and asset
scores were negatively associated with arsenic exposure
and positively associated with size at birth. The mean arse-
nic concentrations in urine were significantly higher during
the postmonsoon period, and size at birth was significantly
lower during the same season. Height, age, education, ges-
tational age at birth, and the sex of infants were associated
with outcomes but not with exposure. However, betel-nut
chewing was associated with arsenic exposure but not with
Figure 2. Association between average arsenic exposure and size at birth by locally weighted regression scatterplot smoothing, showing moving
average-ﬁtted lines among the pregnant women in Matlab, Bangladesh, 2002–2003. Average U-As, average urinary arsenic concentration of early
and late gestational periods. A, birth weight; B, birth length; C, head circumference; D, chest circumference.
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outcomes (data not shown). Among the potential covariates,
body mass index and asset scores were found to change the
effect estimate and thus kept in the final multivariate model.
No dose-effect association was observed between arsenic
exposure and birth weight when evaluating over the full
range of average arsenic exposure (6–978 lg/L) by linear
regression analyses (for a 1-lg/L increase of arsenic in
urine: b coefficient, 0.01 g; standard error (SE), 0.06).
Neither were any of the other anthropometric measurements
(length, head circumference, and chest circumference) as-
sociated with arsenic exposure (data not shown).
When the loess line indicating negative effects at a low
level of average arsenic exposure (51% of women,
<100 lg/L) was statistically tested by use of linear regres-
sion analysis, a significant dose effect of arsenic exposure on
birth weight was confirmed (Table 3). In this range of arse-
nic exposure, each 1-lg/L increase of arsenic concentration
in urine was associated with a 1.68 (SE, 0.62)-g reduction
in birth weight consequently, summing up to a 168-g re-
duction in birth weight when the arsenic exposure exceeded
100 lg/L in urine.
A similar analytical approach was followed in evaluating
the effects of arsenic exposure on birth length, chest circum-
ference, and head circumference. In the lower level of arse-
nic exposure (<100 lg/L), each 1-lg/L increase in average
arsenic concentration was associated with a reduction in
head circumference of 0.05 (SE, 0.03) mm and in chest
circumference of 0.14 (SE, 0.03) mm (Table 3). No associ-
ation was observed with birth length (Table 3).
In addition to the adjustments for asset scores and body
mass index, other covariates (height, age, education, season-
ality, gestational age at birth, and sex of infants) were en-
tered into the model. The effect size for birth weight was
changed from 1.68 (SE, 0.62) g to 1.48 (SE, 0.56) g for
a 1-lg/L increase of arsenic exposure but was still statisti-
cally significant as was the interaction term. Introducing
these additional covariates did not change the effect esti-
mates for head and chest circumferences.
Evaluation of dose effect in the higher level of exposure
by reversing the codes of the categorical variable confirmed
that there was no association between arsenic and birth
weight at an arsenical exposure level of 100 lg/L (for
a 1-lg/L increase of arsenic in urine, adjusted for body mass
index and asset score: b coefficient, 0.004 g; SE, 0.08)
(P ¼ 0.963). Neither did any of the other anthropometric
measurements show a dose effect in the higher range of
exposure.
When evaluating birth anthropometry by measurement of
arsenic at early and late gestational periods, we observed
a sharp initial decrease of birth anthropometry with the loess
line up to 120 lg/L for GW8 and to 100 lg/L for GW30
(data not shown). Statistical testing of the indicated dose
response showed that arsenic exposure in the lower expo-
sure level (<120 lg/L) at GW8 was significantly associated
with head and chest circumferences but not with birth
weight and birth length. Arsenic exposure in the lower ex-
posure level (<100 lg/L) at week 30 was associated with
birth weight and chest circumference but not with head
circumference and birth length (Table 4). There was
no further reduction of birth anthropometry in the higher
exposure level for any of the anthropometric measurements
(Table 4).
DISCUSSION
This study evaluated the effect of individually assessed
arsenic exposure in pregnant women on size at birth in rural
Bangladesh. While there was no dose effect over the full
Table 1. Characteristics of the Cohort of Pregnant Women in
Matlab, Bangladesh, February 2002–January 2003
Variablesa No. %
Age, years
<25 636 40
25–34 760 48
35 182 12
Parity
0 515 33
1 403 25
2 339 22
3 321 20
Body mass index, kg/m2
<18.5 474 30
18.5–24 1,026 65
25 78 5
Education, total years
0 549 35
1–5 337 21
>5 692 44
Average urine arsenic
concentrations, lg/Lb
Mean (SD) 160 (163)
Median 95
10th percentile 26
90th percentile 444
Lowest 6
Highest 978
Abbreviation: SD, standard deviation.
a Results are expressed as percentages unless otherwise
indicated.
b Average arsenic concentrations of early and late gestation.
Table 2. Characteristics of Infants of Pregnancy Cohort in Matlab,
Bangladesh, 2002–2003
Variables
Female (n 5 755),
mean (SD)
Male (n 5 823),
mean (SD)
Birth weight, g 2,633 (378) 2,720 (421)
Birth length, mm 475 (20) 480 (22)
Head circumference, mm 322 (16) 327 (17)
Chest circumference, mm 310 (20) 313 (22)
Abbreviation: SD, standard deviation.
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range of arsenic exposure, a significant dose effect was
found with birth weight in the lower level of exposure. In
this range (0–100 lg/L) of exposure, each 1-lg/L increase
in urinary arsenic concentration was associated with a 1.68-g
reduction in birth weight. The dose effect leveled out, and
no additional negative effect was observed when exposure
exceeded 100 lg/L. We also observed a 0.05-mm and
a 0.14-mm decrease of head and chest circumferences, re-
spectively, for a 1-lg/L increase of arsenic in the exposure
range of <100 lg/L concentration in urine.
In this community-based study, exposure and outcome
data were prospectively collected, and sample size was rea-
sonably large with wide variation of exposure levels. Details
of important covariates that might confound the result were
also available for evaluation. Exposure was assessed objec-
tively by measurement of arsenic concentrations in urine.
The cohort was recruited over an entire year so that any
seasonal variation in exposure and outcome by season
would be represented. We have previously demonstrated
the advantage of assessing arsenic exposure by measure-
ments of concentrations in urine, compared with water
(19), as there is possible additional exposure to arsenic via
food. A likely occurrence of using multiple water sources is
the fact that many women probably used different water
sources after the screening of the wells for arsenic contents
(and painting those with high concentrations red); we col-
lected urine samples twice during pregnancy to catch the
changes in water sources as far as possible.
The epidemiologic design of the study calls for cautious
interpretation of the effect of arsenic at low levels of expo-
sure. The possibility of residual confounding even after ad-
justment with asset score and body mass index may not be
ruled out completely. Even so, further adjustment of biolog-
ically important covariates including height, age, education,
gestational age, and infant’s sex still rendered a significant
association with birth size at low exposure levels. We
did not measure other concurrent exposure in the study
population. The possibility of unmeasured associated expo-
sures at low-dose arsenic levels can not be ruled out. This
might particularly be relevant for manganese, which has
Table 3. Linear Regression of Size at Birth in Relation to Average Urine Arsenic Concentrations
at Lower and Higher Levels of Arsenic Exposure Among Pregnant Women in Matlab,
Bangladesh, 2002–2003
Predicted Variable
and Predictor
Unadjusted Adjusteda
b Coefﬁcient (SE) P Value b Coefﬁcient (SE) P Value
Birth weight, g
U-As concentrationb 1.92 (0.64) 0.003 1.68 (0.62) 0.007
U-As levelc 108.59 (44.60) 0.015 82.42(43.44) 0.058
U-As concentration 3
U-As leveld
1.91 (0.65) 0.003 1.68 (0.63) 0.008
Constant 2,782.12 (32.49) <0.001 2,093.04 (88.15) <0.001
Birth length, mm
U-As concentration 0.07 (0.03) 0.037 0.06 (0.03) 0.078
U-As level 2.09 (2.40) 0.384 0.62 (2.36) 0.792
U-As concentration 3
U-As level
0.06 (0.03) 0.061 0.05 (0.03) 0.118
Constant 481.55 (2.06) 0.000 459.17 (4.79) <0.001
Head circumference, mm
U-As concentration 0.07 (0.03) 0.017 0.05 (0.03) 0.041
U-As level 5.23 (1.91) 0.006 4.069 (1.88) 0.031
U-As concentration 3
U-As level
0.07 (0.03) 0.017 0.06 (0.03) 0.040
Constant 328.71 (1.48) 0.000 307.25 (3.81) <0.001
Chest circumference, mm
U-As concentration 0.16 (0.03) 0.000 0.14 (0.03) <0.001
U-As level 9.79 (2.34) 0.000 8.22 (2.30) <0.001
U-As concentration 3
U-As level
0.16 (0.03) 0.000 0.14 (0.03) <0.001
Constant 321.17 (1.82) 0.000 290.93 (4.66) <0.001
Abbreviations: SE, standard error; U-As, urinary arsenic.
a Adjusted for body mass index and socioeconomic status by asset score.
b Average urinary arsenic concentration (lg/L) (mean of gestational weeks 8 and 30).
c A categorical variable; lower exposure (<100 lg/L) ¼ 0, higher exposure (100 lg/L) ¼ 1.
d Interaction term.
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been found in high concentrations in tube-well water in
Bangladesh (30).
Intrauterine growth depends on multiple factors including
maternal nutrition, food, and micronutrient intake during
pregnancy; physical activity; and environmental toxic ex-
posures in an interplay with genetic predisposition (31).
The mechanisms by which arsenic might affect birth size
are not well understood. Arsenic is known to induce oxida-
tive stress by producing free oxygen radicals or perturbation
of oxidative defense that may cause placental insufficiency
including intrauterine growth retardation (32). Animal stud-
ies have documented arsenic as an endocrine disruptor, al-
tering hormone-activated gene transcription mediated by
the closely related steroid receptors already at very low
doses of exposure (33–35), that may influence the insulin
growth factor system, glucose homeostasis, and cellular
growth.
Epidemiologic studies of the effect of arsenic on fetal and
infant development are scarce, in particular, those address-
ing effects at low exposure levels. A recent study, based on
only 52 pregnant women, reported a significant association
between hair arsenic concentrations and birth weight. How-
ever, the study population profile was not provided, and it
was not clear whether the analyses were adjusted for impor-
tant covariates such as socioeconomic status and women’s
anthropometry (36). Further, the hair arsenic concentration
may be increased from external use of arsenic-contaminated
water. Several studies in Bangladesh have reported in-
creased risk of infant death, blood pressure, and impaired
cognitive development at low arsenical exposure levels, sup-
porting our findings of negative effects at low levels of
exposure (15, 37, 38). Our report of significantly shorter
head circumference may be in line with the reported adverse
effect of arsenic exposure on cognitive development in
childhood, as found in studies in Bangladesh and elsewhere
(38, 39).
As arsenic exposure has been shown to be associated with
fetal losses already at low exposure levels (11, 13–15), the
effect on birth size found in this study may be underesti-
mated. The negative effect of arsenic on birth weight that we
report is on a similar level as what has been reported by
cigarette smoking during pregnancy (40). The magnitude of
this is, in turn, similar to the maximum of what can be
achieved by food supplementation in malnourished women,
albeit the latter is an improvement (29) and, therefore, im-
plies being of public health significance. There was no
Table 4. Linear Regression of Size at Birth in Relation to Urinary Arsenic Concentrations in
Gestational Weeks 8 and 30, at Lower and Higher Levels of Arsenic Exposure Among Pregnant
Women in Matlab, Bangladesh, 2002–2003
Predicted Variable
and Predictor
Urinary Arsenic in
Week 8 (mg/L)
Urinary Arsenic in
Week 30 (mg/L)
b Coefﬁcient (SE)a P Value b Coefﬁcient (SE)a P Value
Birth weight, g
U-As concentrationb 0.59 (0.45) 0.184 1.71 (0.57) 0.003
U-As levelc 61.05 (39.71) 0.124 38.01 (40.25) 0.345
U-As concentration 3
U-As leveld
0.73 (0.45) 0.109 1.58 (80.57) 0.006
Birth length, mm
U-As concentration 0.03 (0.02) 0.260 0.06 (0.03) 0.068
U-As level 2.34 (2.16) 0.271 2.09 (2.19) 0.339
U-As concentration 3
U-As level
0.03 (0.02) 0.206 0.04 (0.03) 0.154
Head circumference, mm
U-As concentration 0.04 (0.02) 0.027 0.03 (0.02) 0.250
U-As level 4.54 (1.72) 0.008 1.17 (0.74) 0.500
U-As concentration 3
U-As level
0.05 (0.02) 0.016 0.03 (0.02) 0.299
Chest circumference, mm
U-As concentration 0.07 (0.02) 0.004 0.13 (0.03) 0.000
U-As level 7.55 (2.10) 0.000 5.96 (2.13) 0.005
U-As concentration 3
U-As level
0.08 (0.02) 0.001 0.12 (0.03) 0.000
Abbreviations: SE, standard error; U-As, urinary arsenic.
a Adjusted for body mass index and socioeconomic status by asset score.
b Urinary arsenic concentration (lg/L) at gestational week 8 or gestational week 30.
c Categorical variable; in gestational week 8, lower exposure (<120 lg/L)¼ 0, higher exposure
(120 lg/L) ¼ 1; in gestational week 30, lower exposure (<100 lg/L) ¼ 0, higher exposure
(100 lg/L) ¼ 1.
d Interaction term.
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further reduction in birth size at a higher level of arsenic
exposure. This might be explained partly by the increased
proportion of fetal losses at high arsenic exposure. Analysis
of the effect of arsenic exposure on fetal losses in this par-
ticular cohort is underway.
In conclusion, at a low level of arsenic exposure, we
observed a significant negative dose effect of prenatal arse-
nic exposure on birth weight, head circumference, and chest
circumference. The effects on birth size found were robust
to adjustment for confounding effect, and the effect estimate
observed has public health significance. No additional neg-
ative effects were observed as exposure increased further.
The indicated negative effect of arsenic already at a low
level of exposure warrants further investigations.
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